BREAST CANCER BASE

Almost all anti-cancer drugs in cell division play a role. As normal cells as cell division frequent, less susceptible to anti-cancer drugs lethal effects. In addition, different anti-cancer drugs, in the role of the different growth stages of the cancer cells, to achieve the greatest extreme <BR> to kill the cancer, and may improve the outcome. Clinical commonly used chemotherapy : ① improved CMF programs; ② AF programs; ③ AC program.

(L) CMF programs;

CTX — cyclophosphamide; MTX — methotrexate 15-Fu — 5-fluorouracil.

CTX600 mg intravenous injection.

MTX1O ~ 15 mg intravenous injection.

As previously stated as breast cancer, medical treatment to surgery, radiotherapy, chemotherapy, hormonal therapy and immune therapy used, with the Prevention and Treatment of Cancer Research and Development, Chinese medicine in the treatment of breast cancer play a greater role, has its unique advantages.
(1) prevention of radiotherapy and chemotherapy side effects and improve efficacy : Yiqi Yangxue selection, Spleen and stomach, nourishing the liver and kidney medicine such as fungus, Astragalus, Wong Ching, dangshen, Atractylodes, Poria, Citrus, money Banxia, Gallus gallus domesticus, medlar of Some chemotherapy can significantly reduce caused by gastrointestinal and bone marrow suppression response. Using Qingrejiedu, Yiqiyangyin law, can significantly reduce breast cancer patients radiotherapy emerge during the process of radioactive dermatitis, radioactive reaction such as pneumonia, plus appropriate Chongqing 400016 goods with the ability to achieve synergies radiotherapy purposes.
(2) anti-tumor effects : Whether to reinstate the pui, Huoxue Huayu, or Qingrejiedu, Huatan Qushi Chinese herbs have some anti-tumor effect of physical weakness, not OK radiotherapy or surgical treatment of breast cancer patients with radiotherapy and chemotherapy in patients with intermittent period can achieve effective control of tumor to prevent the recurrence and metastasis of purpose and application of simple, minor side effects, some have been proved through practice to a double of proprietary Chinese medicine maker, Genentech and cancer-tabs, of which two-maker, Genentech is the only type of Ganoderma anticancer medicine.
(3) "The overall concept" as the guiding ideology for stress, illness, the results of treatment. To Differential Treatment to the principle of the function of the body are better regulatory role. If the regulation of immune function, strengthen the body's defenses; Improve blood clotting; Regulation of the fluid balance and endocrine function; To improve bone marrow function; Anti-inflammatory and anti-infection; Adjustment of connective tissue metabolism and reduce the radiation, such as fibrosis.
(4) easy to use, indications Canton. Both preoperative or postoperative chemotherapy or during or gap period, or early or late applications can be Chinese medicine. Medicines rich source of economic convenience, Oral and topical, can cause pills, powder, ointment, tincture various dosage forms, depending on the patient's specific situation flexible use. 

For ER / PR positive only bone / tissue transfer or asymptomatic visceral metastasis in patients with breast cancer, dealing with the following principles : (a) For the year received anti-estrogen treatment of patients with the option of aromatase inhibitors or progesterone hormones or other endocrine drug therapy, straight tumor progression to occur or tolerance of toxicity. If the tumor further progress, and accept a three rescue endocrine treatment programs, not clinical benefit or any of the symptoms associated with visceral metastasis, one can consider switching to systemic chemotherapy, on the other hand may also consider accepting new endocrine therapy clinical trials. (2) not previously received anti-estrogen therapy, or anti-estrogen therapy has been more than a year of patients. If for postmenopausal patients, it may consider preferred or anti-estrogen drug therapy; If not menopausal patients should first conduct ovariectomized or inhibit ovarian function and click postmenopausal principles, preferred choice or anti-estrogen therapy. If the tumor further progress, and accept a three rescue endocrine treatment programs, not clinical benefit or any of the symptoms associated with visceral metastasis, one can consider switching to systemic chemotherapy, on the other hand may also consider accepting new endocrine therapy clinical trials. But special emphasis on the need for the past received anti-estrogen treatment, which has more than a year of patients, although in 2006 NCCN treatment guidelines that can use anti-estrogen therapy. But Furlong P025 tests show that used auxiliary TAM, to stop more than a year of failure patients, and then only TAM efficiency 8%. Therefore we believe that this group of patients should be possible to evade the TAM option to switch to anastrozole.